/PRNewswire/ The "North America ECMO Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality, Application, and Age Group" report has.
Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire .
Johnson & Johnson (JNJ) Acquires Abiomed (ABMD) for $380/sh or $16.6B, Plus CVR Worth Up to $35/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Stock Market | Daily Herald dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.